Categoria

Immediapress- Pagina 515

3 minuti di lettura

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease TAMPA, Florida, Nov. 2, 2026 /PRNewswire/ —

Immediapress

Catalyx Launches OpenLine to Bring Regulatory-Grade Control and Higher Throughput to High-Speed Manufacturing

New platform connects AI-driven and traditional machine vision, equipment and enterprise systems so production lines operate as one NEWTOWN, Pa., Nov. 2, 2026 /PRNewswire/ — Catalyx today launched OpenLine, an intelligent platform that connects AI-driven and traditional vision systems, production devices

Alibaba Brings Cloud and AI to the First Youth Olympic Games in Africa

Immediapress

DAKAR, SENEGAL – Media OutReach Newswire – 2 November 2026 – In a historic milestone for African sport, Alibaba Group, in partnership with

La Corte federale di giustizia tedesca emette una decisione storica nella causa promossa da Alisher Usmanov contro il Consiglio dell’UE

Immediapress

BERLINO, 2 novembre 2026 /PRNewswire/ — La Corte federale di giustizia tedesca (BGH) ha stabilito che il rifiuto del presidente del Tribunale regionale di

UAE’s e& Joins MagicCube’s $10M Round to Advance Sovereign-Grade Post-Quantum Security for AI, Identity, and Payments

martedì, 28 Aprile 2026

Immediapress

CUPERTINO, Calif., April 28, 2026 /PRNewswire/ — MagicCube, the pioneer of software-based security for payments, identity, and digital assets, today announced that e& capital, the investment arm of global technology group e&,

World’s First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical

martedì, 28 Aprile 2026

Immediapress

CHONGQING, China, April 28, 2026 /PRNewswire/ — Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China’s National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project

World’s First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical

martedì, 28 Aprile 2026

Immediapress

Sound and Style Combined: DJI Mic Mini 2 Delivers Upleveled Audio and All-In-One Storage

martedì, 28 Aprile 2026

Immediapress

Going Beyond Sound, DJI’s Compact Wireless Microphone Features Colorful Front Covers To Match Any Style SHENZHEN, China, April 28, 2026 /PRNewswire/ — DJI, the global leader in civilian drones and creative camera

Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers’ EOR Operations

martedì, 28 Aprile 2026

Immediapress

One global brand. 38 owned legal entities. Coverage in 180+ countries, serving companies and professionals wherever work happens. LONDON and DUBAI, UAE, April 28, 2026 /PRNewswire/ — Hightekers, Eos Global Expansion,

Echosens nomina Romain Baujard amministratore delegato del Gruppo

martedì, 28 Aprile 2026

Immediapress

L’azienda intende accelerare i tempi nel rendere la salute del fegato un indicatore vitale nella cura delle patologie cardiometaboliche; la nomina segue il pensionamento dell’attuale AD del Gruppo Dominique Legros PARIGI, 28

Benvenuti! Alaska Airlines launches historic first nonstop flight between Seattle and Rome

martedì, 28 Aprile 2026

Immediapress

SEATTLE, April 28, 2026 /PRNewswire/ — Alaska Airlines today marks a major milestone with the launch of its inaugural nonstop flight between Seattle and Rome, the first-ever direct connection between the Emerald